Evidence map›Paper›PMID 32235333›Full record

ReviewMolecules (Basel, Switzerland)2020

Terpenoids, Cannabimimetic Ligands, beyond the

Elaine C D Gonçalves, Gabriela M Baldasso, Maíra A Bicca, Rodrigo S Paes, Raffaele Capasso, Rafael C Dutra

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. The Effects of Cannabinoids on Ischemic Stroke-Associated Neuroinflammation: A Systematic Review.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Pooled it
  2. Review
  3. Selected Cannabinoids, Cannabimimetic Agents andPharmaceuticals (Basel, Switzerland) · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. The Known Unknowns: An Enigmatic Pathway of CCurrent issues in molecular biology · 2025
    Review
  8. Review
  9. Pharmacokinetics of cannabidiol, (-)-Frontiers in veterinary science · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. The Use of Compounds Derived fromInternational journal of molecular sciences · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Elaine C D GonçalvesLaboratory of Autoimmunity and Immunopharmacology (LAIF), Department of Health Sciences, Campus Araranguá, Universidade Federal de Santa Catarina, Araranguá 88906-072, Brazil.ORCID 0000-0003-0682-3019
Gabriela M BaldassoLaboratory of Autoimmunity and Immunopharmacology (LAIF), Department of Health Sciences, Campus Araranguá, Universidade Federal de Santa Catarina, Araranguá 88906-072, Brazil.ORCID 0000-0002-6254-2812
Maíra A BiccaNeurosurgery Department, Neurosurgery Pain Research institute, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0002-3648-8824
Rodrigo S PaesLaboratory of Autoimmunity and Immunopharmacology (LAIF), Department of Health Sciences, Campus Araranguá, Universidade Federal de Santa Catarina, Araranguá 88906-072, Brazil.ORCID 0000-0002-2330-4862
Raffaele CapassoDepartment of Agricultural Sciences, University of Naples Federico II, 80,055 Portici, Italy.ORCID 0000-0002-3335-1822
Rafael C DutraLaboratory of Autoimmunity and Immunopharmacology (LAIF), Department of Health Sciences, Campus Araranguá, Universidade Federal de Santa Catarina, Araranguá 88906-072, Brazil.ORCID 0000-0002-6938-2161
Universidade Federal de Santa Catarina · BRJohns Hopkins University · USUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medicinal use of

Indexed as

Alzheimer DiseaseAnxietyBicyclic MonoterpenesCannabidiolCannabinoid Receptor AgonistsCannabisCognitive DysfunctionDronabinolHumansInflammatory Bowel DiseasesNeuralgiaNeuroprotective AgentsNootropic AgentsSchizophreniaSesquiterpenesTerpenesalpha-pineneBicyclic MonoterpenescampheneCannabidiolCannabinoid Receptor AgonistsDronabinolelemeneNeuroprotective AgentsNootropic AgentsSesquiterpenesTerpenescannabinoid receptorsCannabis plantendocannabinoidsinflammation.phytocannabinoidterpenoids

Identifiers

PMID32235333
PMCPMC7181184
OpenAlexW3013206967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.